Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cance

[News]

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk triple-negative breast cancer patients.

More... (https://www.news-medical.net/news/20241117/Neoantigen-DNA-vaccines-improve-survival-and-immunity-in-triple-negative-breast-cancer-patients.aspx)